The emergence of COVID-19 has presented multifaceted challenges for healthcare systems globally. Among these, the incidence of acute kidney injury (AKI) in patients affected by the virus has been increasingly recognized as a factor significantly influencing morbidity and mortality rates. This retrospective cohort study aims to elucidate the prevalence, characteristics, and outcomes of AKI among hospitalized patients with COVID-19. The association of AKI with elevated mortality rates underscores the need for vigilant monitoring and strategic interventions to improve patient outcomes in this vulnerable cohort.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: